![Ronit Bakimer-Kleiner](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Ronit Bakimer-Kleiner served as the Chief Development Officer at Cellect Biotechnology Ltd.
from 2017 to 2019.
Prior to this, he obtained an undergraduate degree from Tel-Aviv University and graduate and doctorate degrees from Ben-Gurion University of the Negev.
Eerdere bekende functies van Ronit Bakimer-Kleiner
Bedrijven | Functie | Einde |
---|---|---|
QUOIN PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 03-08-2019 |
Opleiding van Ronit Bakimer-Kleiner
Tel-Aviv University | Undergraduate Degree |
Ben-Gurion University of the Negev | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Cellect Biotechnology Ltd.
![]() Cellect Biotechnology Ltd. Medical SpecialtiesHealth Technology Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. | Health Technology |